T. Greten

Immune based therapies in cancer.

F. Korangy, C. Krüger, T. Greten, 2007, Histology and histopathology.

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer

S. Steinberg, M. Raffeld, E. Levy, 2016, International journal of cancer.

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib

S. Steinberg, P. Choyke, T. Greten, 2015, United European gastroenterology journal.

Molecular therapy for the treatment of hepatocellular carcinoma

M. Manns, T. Greten, F. Korangy, 2008, British Journal of Cancer.